Liquid chromatography with a column-switching technique was developed for simultaneous direct quantification of levofloxacin, gatifloxacin and moxifloxacin in human serum. Serum samples were injected on a LiChroCART 4-4 pre-column (PC) filled with a LiChrospher 100 RP-18, 5 microm where fluoroquinolones (FQs) were purified and concentrated. The FQs were back-flushed from the PC and then separated on a Supelcosil ABZ+ Plus (150 mm x 4.6 mm i.d.) analytical column with a mobile phase containing 10 mM phosphate buffer (pH 2.5), acetonitrile (88:12, v/v) and 2mM tetrabutyl ammonium bromide. The effects of ion-pair reagents, buffer type, pH and acetonitrile concentrations in the mobile phase on the separation of the three FQs were investigated. Fluorescence detection provided sufficient sensitivity to achieve a quantification limit of 125 ng/ml for levofloxacin and moxifloxacin; 162.5 ng/ml for gatifloxacin with a 5 microl sample size. The on-line process of extraction avoids time-consuming treatment of the samples before injection and run time is shortened. The recovery, selectivity, linearity, precision and accuracy of the method are convenient for pharmacokinetic studies or routine assays.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jchromb.2004.07.019 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Rifampicin and isoniazid resistance not promote fluoroquinolone resistance in Mycobacterium smegmatis.
PLoS One
January 2025
National Clinical Research Center for Infectious Diseases, Shenzhen Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Shenzhen, Guangdong, China.
Background: The emergence of drug-resistant Tuberculosis (TB) has made treatment challenging. Although fluoroquinolones (FQs) are used as key drugs in the treatment of multidrug-resistant tuberculosis (MDR-TB), the problem of FQs resistance is becoming increasingly serious. Rifampicin (RIF) resistance is considered a risk factor for FQs resistance.
View Article and Find Full Text PDFThelaziasis in an urban woman in Beijing: a case report and literature review.
BMC Ophthalmol
November 2024
Department of Ophthalmology, Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Peking University Third Hospital, No 49 North Garden Road, Haidian District, Beijing, 100191, China.
Article Synopsis
- Thelaziasis, caused by the parasitic worm Thelazia callipaeda, leads to various eye-related symptoms, potentially resulting in serious conditions like conjunctivitis or blindness, particularly in areas with contact to domestic animals.
- A 41-year-old woman experienced persistent eye discomfort attributed to Thelazia callipaeda, despite initial treatments, but underwent successful removal of the worms from her eye.
- The case emphasizes the need for healthcare professionals to consider parasitic infections in diagnosing eye issues, even in urban settings, and suggests that regional studies on the prevalence of human thelaziasis in China are necessary.
Investigating the hypothermic effects of fluoroquinolone antimicrobials on non-bacterial fever model mice.
J Pharm Health Care Sci
November 2024
Division of Pharmacodynamics, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-Ku, Tokyo, 105-8512, Japan.
Background: Fluoroquinolone (FQ) antimicrobials have antipyretic effects during the treatment of bacterial infections; however, it is not clear whether these are due to their antimicrobial activities or their hypothermic effects. In this study, we investigated the hypothermic effects of FQ antimicrobials (ciprofloxacin [CPFX], gatifloxacin [GFLX], and levofloxacin [LVFX]) on fever by evaluating rectal body temperature changes in a mouse model of non-bacterial fever.
Methods: CPFX, GFLX, and LVFX were administered intraperitoneally to non-bacterial fever model mice induced by yeast.
Comparison of Mutant Prevention Concentrations of Fluoroquinolones Against ESBL-Positive and ESBL-Negative Isolates from Orthopedic Patients.
Microb Drug Resist
September 2024
The Department of Orthopedics, Zhengzhou Seventh People's Hospital, Zhengzhou, China.
The majority of isolates possess the extended-spectrum beta-lactamase (ESBL) enzymes. Therefore, can easily develop drug resistance. How to effectively overcome the problem of drug resistance in is still a research hotspot.
View Article and Find Full Text PDFAssociation Between Fluoroquinolones and Major Adverse Cardiovascular Events: A Systematic Review.
Cardiol Rev
April 2024
Department of Immunology and Rheumatology, Stanford University, CA.
Fluoroquinolones (FQs) are routinely administered antibiotics that have demonstrated an increased propensity to cause major adverse cardiovascular events (MACE). We conducted a systematic review aimed to investigate the association between FQ usage and the risk of MACE. A comprehensive literature search was conducted using PubMed, Scopus, and the Cochrane Library from inception to September 2023 to retrieve studies comparing FQ administration with placebo and reporting the occurrence of MACE.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!